These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21894018)

  • 1. Plasma viscosity in giant cell arteritis.
    Finke C; Schroeter J; Kalus U; Ploner CJ
    Eur Neurol; 2011; 66(3):159-64. PubMed ID: 21894018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis.
    Parikh M; Miller NR; Lee AG; Savino PJ; Vacarezza MN; Cornblath W; Eggenberger E; Antonio-Santos A; Golnik K; Kardon R; Wall M
    Ophthalmology; 2006 Oct; 113(10):1842-5. PubMed ID: 16884778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal artery biopsy is not required in all cases of suspected giant cell arteritis.
    Quinn EM; Kearney DE; Kelly J; Keohane C; Redmond HP
    Ann Vasc Surg; 2012 Jul; 26(5):649-54. PubMed ID: 22285348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Giant cell arteritis with low erythrocyte sedimentation rate: frequency of occurence in a population-based study.
    Salvarani C; Hunder GG
    Arthritis Rheum; 2001 Apr; 45(2):140-5. PubMed ID: 11324777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Masked giant cell arteritis.
    Cheung PP; Richards G
    Aust Fam Physician; 2006 Nov; 35(11):893-5. PubMed ID: 17099811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma viscosity and the diagnosis of giant cell arteritis.
    Orrell RW; Johnson MH
    Br J Clin Pract; 1993; 47(2):71-2. PubMed ID: 8334065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymyalgia rheumatica and giant cell arteritis--An ophthalmic emergency.
    Durkin SR; Athanasiov PA; Crompton JL
    Aust Fam Physician; 2006 Nov; 35(11):889-91. PubMed ID: 17099810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of giant cell arteritis: interleukin-6 as a biologic marker of disease activity.
    Weyand CM; Fulbright JW; Hunder GG; Evans JM; Goronzy JJ
    Arthritis Rheum; 2000 May; 43(5):1041-8. PubMed ID: 10817557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical features and treatment of giant cell arteritis in Chinese, a prospective study].
    Hu Z; Yang Q; Li J; Zeng S; Wu X; Cao L; Yang L; Song X
    Zhonghua Yi Xue Za Zhi; 2002 Apr; 82(7):453-5. PubMed ID: 12133513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Equivalence of the acute phase reactants C-reactive protein, plasma viscosity, and Westergren erythrocyte sedimentation rate when used to calculate American College of Rheumatology 20% improvement criteria or the Disease Activity Score in patients with early rheumatoid arthritis. Western Consortium of Practicing Rheumatologists.
    Paulus HE; Ramos B; Wong WK; Ahmed A; Bulpitt K; Park G; Sterz M; Clements P
    J Rheumatol; 1999 Nov; 26(11):2324-31. PubMed ID: 10555885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Giant cell arteritis and normal sedimentation rate: more than an exception!].
    von Blotzeim SG; Borruat FX
    Klin Monbl Augenheilkd; 1996 May; 208(5):397-9. PubMed ID: 8766063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validity of the American College of Rheumatology criteria for the diagnosis of giant cell arteritis.
    Murchison AP; Gilbert ME; Bilyk JR; Eagle RC; Pueyo V; Sergott RC; Savino PJ
    Am J Ophthalmol; 2012 Oct; 154(4):722-9. PubMed ID: 22809782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silent, or masked, giant cell arteritis is associated with a strong inflammatory response and a benign short term course.
    Liozon E; Boutros-Toni F; Ly K; Loustaud-Ratti V; Soria P; Vidal E
    J Rheumatol; 2003 Jun; 30(6):1272-6. PubMed ID: 12784402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The value of anamnesis, clinical findings and laboratory parameters in the diagnosis of giant cell arteritis].
    Pompecki R; Erdogan S; Conic B; Frenzel H
    Z Gerontol; 1988; 21(5):253-6. PubMed ID: 3239146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Giant cell arteritis: diagnosing and treating inflammatory disease in older adults.
    Azhar SS; Tang RA; Dorotheo EU
    Geriatrics; 2005 Aug; 60(8):26-30. PubMed ID: 16092890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble interleukin 2 receptors in polymyalgia rheumatica/giant cell arteritis. Clinical and laboratory correlations.
    Salvarani C; Macchioni P; Boiardi L; Rossi F; Casadei Maldini M; Mancini R; Beltrandi E; Spacca C; Lodi L; Portioli I
    J Rheumatol; 1992 Jul; 19(7):1100-6. PubMed ID: 1512765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of the role of temporal artery biopsy in diagnosing clinically suspected giant cell arteritis.
    Varma D; O'Neill D
    Eye (Lond); 2004 Apr; 18(4):384-8. PubMed ID: 15069435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Giant cell arteritis and polymyalgia rheumatica: diagnosis and evolution of 90 cases].
    Rivero Puente A; Berasategui Calderón JI; Murie Carrillo De Albornoz JM; Rivero Marcotegui M; García-Bragado Acín F
    An Med Interna; 2001 Apr; 18(4):191-4. PubMed ID: 11496538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin or nonsteroidal anti-inflammatory drug use is associated with lower erythrocyte sedimentation rate in patients with giant cell arteritis.
    Hegg R; Lee AG; Tagg NT; Zimmerman MB
    J Neuroophthalmol; 2011 Jun; 31(2):135-8. PubMed ID: 21358421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma viscosity or erythrocyte sedimentation rate in the diagnosis of giant cell arteritis?
    Brittain GP; McIlwaine GG; Bell JA; Gibson JM
    Br J Ophthalmol; 1991 Nov; 75(11):656-9. PubMed ID: 1751458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.